155 related articles for article (PubMed ID: 30770626)
1. LEF1-AS1, long non-coding RNA, inhibits proliferation in myeloid malignancy.
Congrains-Castillo A; Niemann FS; Santos Duarte AS; Olalla-Saad ST
J Cell Mol Med; 2019 Apr; 23(4):3021-3025. PubMed ID: 30770626
[TBL] [Abstract][Full Text] [Related]
2. LncRNA landscape analysis identified LncRNA LEF-AS1 as an oncogene that upregulates LEF1 and promotes survival in chronic lymphocytic leukemia.
Du X; Liu H; Yang C; Shi X; Cao L; Zhao X; Miao Y; Zhu H; Wang L; Xu W; Li J; Fan L
Leuk Res; 2021 Nov; 110():106706. PubMed ID: 34563944
[TBL] [Abstract][Full Text] [Related]
3. LEF1-AS1 is implicated in the malignant development of glioblastoma via sponging miR-543 to upregulate EN2.
Zeng S; Zhou C; Yang DH; Xu LS; Yang HJ; Xu MH; Wang H
Brain Res; 2020 Jun; 1736():146781. PubMed ID: 32184164
[TBL] [Abstract][Full Text] [Related]
4. lncRNA
Yang J; Lin X; Jiang W; Wu J; Lin L
DNA Cell Biol; 2019 Sep; 38(9):1013-1021. PubMed ID: 31386568
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA LEF1-AS1 silencing suppresses the initiation and development of prostate cancer by acting as a molecular sponge of miR-330-5p via LEF1 repression.
Liu DC; Song LL; Liang Q; Hao L; Zhang ZG; Han CH
J Cell Physiol; 2019 Aug; 234(8):12727-12744. PubMed ID: 30613973
[TBL] [Abstract][Full Text] [Related]
6. LEF1-AS1 contributes to proliferation and invasion through regulating miR-544a/ FOXP1 axis in lung cancer.
Wang A; Zhao C; Gao Y; Duan G; Yang Y; Fan B; Wang X; Wang K
Invest New Drugs; 2019 Dec; 37(6):1127-1134. PubMed ID: 30734202
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of lncRNA LEF1-AS1 inhibited the progression of oral squamous cell carcinoma (OSCC) via Hippo signaling pathway.
Zhang C; Bao C; Zhang X; Lin X; Pan D; Chen Y
Cancer Biol Ther; 2019; 20(9):1213-1222. PubMed ID: 30983488
[TBL] [Abstract][Full Text] [Related]
8. CREB1-induced lncRNA LEF1-AS1 contributes to colorectal cancer progression via the miR-489/DIAPH1 axis.
Cheng Y; Wu J; Qin B; Zou BC; Wang YH; Li Y
Biochem Biophys Res Commun; 2020 Jun; 526(3):678-684. PubMed ID: 32248974
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA LEF1-AS1 binds with HNRNPL to boost the proliferation, migration, and invasion in osteosarcoma by enhancing the mRNA stability of LEF1.
Lu X; Qiao L; Liu Y
J Cell Biochem; 2020 Oct; 121(10):4064-4073. PubMed ID: 31930565
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of long noncoding RNA LEF1-AS1 predicts a poor prognosis in patients with esophageal squamous cell carcinoma.
Zong MZ; Feng WT; Du N; Yu XJ; Yu WY
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7929-7934. PubMed ID: 31599448
[TBL] [Abstract][Full Text] [Related]
11. LncRNA LEF1-AS1 regulates the migration and proliferation of vascular smooth muscle cells by targeting miR-544a/PTEN axis.
Zhang L; Zhou C; Qin Q; Liu Z; Li P
J Cell Biochem; 2019 Sep; 120(9):14670-14678. PubMed ID: 31016789
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA LEF1-AS1 is involved in the progression of retinoblastoma through regulating the Wnt/β-catenin pathway.
He H; Qin M
Clin Exp Pharmacol Physiol; 2020 May; 47(5):886-891. PubMed ID: 31990064
[TBL] [Abstract][Full Text] [Related]
13. Differences in expression and function of LEF1 isoforms in normal versus leukemic hematopoiesis.
Feder K; Edmaier-Schröger K; Rawat VPS; Kirsten N; Metzeler K; Kraus JM; Döhner K; Döhner H; Kestler HA; Feuring-Buske M; Buske C
Leukemia; 2020 Apr; 34(4):1027-1037. PubMed ID: 31758089
[TBL] [Abstract][Full Text] [Related]
14. LncRNA USP30-AS1 promotes the survival of acute myeloid leukemia cells by cis-regulating USP30 and ANKRD13A.
Zhou W; Xu S; Deng T; Zhou R; Wang C
Hum Cell; 2022 Jan; 35(1):360-378. PubMed ID: 34694569
[TBL] [Abstract][Full Text] [Related]
15. LEF-1 drives aberrant β-catenin nuclear localization in myeloid leukemia cells.
Morgan RG; Ridsdale J; Payne M; Heesom KJ; Wilson MC; Davidson A; Greenhough A; Davies S; Williams AC; Blair A; Waterman ML; Tonks A; Darley RL
Haematologica; 2019 Jul; 104(7):1365-1377. PubMed ID: 30630973
[TBL] [Abstract][Full Text] [Related]
16. lncRNA FBXL19-AS1 is a diagnosis biomarker for paediatric patients with acute myeloid leukemia.
Sheng H; Zhang J; Ma Y; Zhang Y; Dai Y; Jiang R
J Gene Med; 2021 Mar; 23(3):e3317. PubMed ID: 33474753
[TBL] [Abstract][Full Text] [Related]
17. Marked downregulation of the granulopoiesis regulator LEF1 is associated with disease progression in the myelodysplastic syndromes.
Pellagatti A; Marafioti T; Paterson JC; Malcovati L; Della Porta MG; Jädersten M; Pushkaran B; George TI; Arber DA; Killick S; Giagounidis A; Hellström-Lindberg E; Cazzola M; Wainscoat JS; Boultwood J
Br J Haematol; 2009 Jun; 146(1):86-90. PubMed ID: 19438482
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of lymphoid enhancer-binding factor 1 expression in acute myeloid leukemia.
Fu Y; Zhu H; Wu W; Xu J; Chen T; Xu B; Qian S; Li J; Liu P
Leuk Lymphoma; 2014 Feb; 55(2):371-7. PubMed ID: 23713453
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA SBF2-AS1 act as a ceRNA to modulate cell proliferation via binding with miR-188-5p in acute myeloid leukemia.
Tian YJ; Wang YH; Xiao AJ; Li PL; Guo J; Wang TJ; Zhao DJ
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1730-1737. PubMed ID: 31062614
[TBL] [Abstract][Full Text] [Related]
20.
Wang J; Liu X; Yan C; Liu J; Wang S; Hong Y; Gu A; Zhao P
Onco Targets Ther; 2017; 10():4251-4260. PubMed ID: 28894380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
